PMC:7402624 / 60028-60278
Annnotations
LitCovid-PD-FMA-UBERON
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T507 | 31-41 | Body_part | denotes | lymphocyte | http://purl.org/sig/ont/fma/fma62863 |
T508 | 236-240 | Body_part | denotes | cell | http://purl.org/sig/ont/fma/fma68646 |
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
1918 | 107-115 | Species | denotes | patients | Tax:9606 |
1919 | 171-179 | Species | denotes | patients | Tax:9606 |
1925 | 98-106 | Disease | denotes | COVID-19 | MESH:C000657245 |
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T405 | 98-106 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T916 | 42-52 | http://purl.obolibrary.org/obo/CLO_0001658 | denotes | activation |
T917 | 123-124 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T918 | 209-210 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T919 | 234-240 | http://purl.obolibrary.org/obo/CL_0000236 | denotes | B cell |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T20552 | 218-227 | Chemical | denotes | antiviral | http://purl.obolibrary.org/obo/CHEBI_22587 |
LitCovid-PD-GO-BP
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T126 | 31-52 | http://purl.obolibrary.org/obo/GO_0046649 | denotes | lymphocyte activation |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T348 | 0-250 | Sentence | denotes | Immunotype 3, in which minimal lymphocyte activation response was observed, may represent ~20% of COVID-19 patients and is a potentially important scenario to consider as patients who may have failed to mount a robust antiviral T and B cell response. |